Publication: 575

Publication: 575

NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study

URL

Google Scholar

Citation:: J Clin Oncol vol 29 (suppl) abstr 2033

Meeting Instance:: ASCO 2011
Year:: 2011
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2773

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: K. A. Jaeckle D. Schiff S. K. Anderson E. Galanis P. J. Stella P. J. Flynn J. N. Sarkaria B. W. Scheithauer B. J. Erickson J. C. Buckner

Networks:

Study: NCCTG-N0572
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: